The vaccine was shown to generate a potent immune response without causing harm. Hope for genital warts comes with Cantab s TA-GW, which has been successful in greatly lowering the recurrence rate of genital warts. Cantab is a British biotech specialized in immunology, especially virology. It is developing products that aim at preventing and curing chronic viral disease that currently have no effective treatments. GlaxoWellcome and SmithKline are partners in the herpes vaccine and the wart vaccine respectively.
Cash There is no problem with cash.
The firm has enough to cover at least two or three years of spending. Revenues are injected through the alliances that are enthusiastic about Cantab s products. Compared to other firms in the immunotherapy group, Cantab is undervalued. The stock was slashed in the turbulent market. It will rebound.